,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-03-23 00:40:00,"Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Amgen (AMGN) and Walgreens Boots Alliance (WBA).",0.044635627418756485,0.008207813836634159,0.9471566081047058,neutral,0.0364278145134449
1,2017-03-23 00:40:00,"Berkshire Hathaway shares have lost ground lately, with the stock lagging the broader market since March 1st.",0.01900234818458557,0.9697757959365845,0.01122190710157156,negative,-0.9507734775543213
2,2017-03-23 00:40:00,But the stock has done better than the S&P 500 index and about in-line with the Zacks Finance sector.,0.9239665269851685,0.04206547886133194,0.033967941999435425,positive,0.8819010257720947
3,2017-03-23 00:40:00,"The insurance business, which remains at the core of this financial conglomerate's business portfolio, is as much a beneficiary of the post-election momentum in interest rates as are traditional banks and brokers.",0.44045600295066833,0.010827488265931606,0.5487164855003357,neutral,0.42962852120399475
4,2017-03-23 00:40:00,"But Berkshire Hathaway is more than insurance - it has assets in the railroads, oil pipelines and many other spaces.",0.04801330715417862,0.005957338493317366,0.9460293650627136,neutral,0.042055968195199966
5,2017-03-23 00:40:00,"The company's name has long been synonymous with Warren Buffet, concerns about whose succession have been an issue for the stock.",0.0847916454076767,0.3630581200122833,0.5521502494812012,neutral,-0.2782664895057678
6,2017-03-23 00:40:00,The company is expected to report first quarter results on May 5th.,0.03974716365337372,0.005500602535903454,0.9547522664070129,neutral,0.03424656018614769
7,2017-03-23 00:40:00,"(You can read the full research report onBerkshire Hathaway here >> )

Amgen shares struggled last year, but came back following the election as fears of restrictive pricing and regulatory strictures eased.",0.5035374164581299,0.4592466354370117,0.037215977907180786,positive,0.044290781021118164
8,2017-03-23 00:40:00,"The stock has been down in a big way since March 1st, but has still done better than the peer group over the past year.",0.040106095373630524,0.9364017248153687,0.02349221520125866,negative,-0.8962956070899963
9,2017-03-23 00:40:00,Amgen is well positioned for growth with several blockbuster drugs in its portfolio.,0.8630673289299011,0.011561359278857708,0.12537133693695068,positive,0.8515059947967529
10,2017-03-23 00:40:00,"Amgen's growth products - Prolia, Xgeva, Vectibix, Nplate and Sensipar - are all performing well.",0.9329546689987183,0.01515250001102686,0.051892735064029694,positive,0.9178021550178528
11,2017-03-23 00:40:00,"Additionally, Amgen's restructuring plan should make it leaner and more cost efficient.",0.8799545168876648,0.013725902885198593,0.10631956160068512,positive,0.8662286400794983
12,2017-03-23 00:40:00,Amgen is also progressing with its pipeline given quite a few regulatory and data updates scheduled for the coming quarters.,0.9085344076156616,0.014826233498752117,0.07663942873477936,positive,0.8937081694602966
13,2017-03-23 00:40:00,"(You can read the full research report onAmgen here >> )

Walgreens Boots shares have done better than the Zacks Retail-Drug Stores industry in the year-to-date period (WBA is up +0.4% vs. decline of -1.9% for the peer group), but the stock has lagged the broader Zacks Retail sector in that same time period.",0.8849773406982422,0.08832814544439316,0.026694616302847862,positive,0.7966492176055908
14,2017-03-23 00:40:00,Uncertainty about the Rite Aid tie up and a recent track record of margin pressures have been weighing on the stock.,0.023841317743062973,0.939880907535553,0.03627782687544823,negative,-0.9160395860671997
15,2017-03-23 00:40:00,"The company is expected to report first-quarter results on April 5th, with the current Zacks Consensus EPS of $1.35 on $30.7 billion in revenues essentially stable in recent days.",0.7960883378982544,0.04814917594194412,0.1557624191045761,positive,0.7479391694068909
16,2017-03-23 00:40:00,"While concerns remain about regulatory hurdles to the Rite Aid transaction, the company appears on track to execute on its cost reduction plan that is expected to strengthen margins.",0.9424862265586853,0.024880200624465942,0.03263365104794502,positive,0.917605996131897
17,2017-03-23 00:40:00,"A strong balance sheet and a track record of returning excess cash to shareholders (pays an attractive dividend, currently yielding 1.8%) are some of the other positives in the Walgreens story.",0.7243845462799072,0.01513095386326313,0.2604844570159912,positive,0.7092536091804504
18,2017-03-23 00:40:00,"(You can read the full research report onWalgreens Boots here >> )

Other noteworthy reports we are featuring today include Procter & Gamble Co (PG), General Electric Company (GE) and Carnival Corp (CCL).",0.02533937431871891,0.00684042414650321,0.9678202271461487,neutral,0.018498949706554413
19,2017-03-23 00:40:00,"Starting today, you are invited to download in-depth analysis reports covering more than 1,000 of the most widely followed stocks.",0.040785253047943115,0.008477886207401752,0.9507368803024292,neutral,0.03230736777186394
20,2017-03-23 00:40:00,"Valued at $25 each, they are yours to consult over the next 30 days absolutely free.",0.03975151479244232,0.0066274418495595455,0.9536210894584656,neutral,0.03312407433986664
21,2017-03-23 00:40:00,They feature sensitive Zacks Rank information on each stock that you won't find anywhere else.,0.027265066280961037,0.022345593199133873,0.9503893852233887,neutral,0.004919473081827164
22,2017-03-23 00:40:00,"See the reports free >>

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings.",0.11193089932203293,0.007970723323523998,0.8800983428955078,neutral,0.10396017879247665
23,2017-03-23 00:40:00,He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports.,0.023997269570827484,0.008975164964795113,0.9670275449752808,neutral,0.015022104606032372
24,2017-03-23 00:40:00,"If you want an email notification each time Sheraz publishes a new article, please click here >>>

The Zacks analyst believes Progressive's efforts to penetrate customer households through cross-selling auto policies will boost its customer base and revenues

Per the Zacks analyst, Humana's acquisitions, efficient capital deployment, business diversification initiatives paves way for long term growth

According to the covering analyst, Magellan Midstream's fee-based transportation and storage assets make it less susceptible to commodity price weakness.",0.8061967492103577,0.027727581560611725,0.16607561707496643,positive,0.7784691452980042
25,2017-03-23 00:40:00,"Although concerned about the company's high debt levels and increasing costs, the covering analyst is positive about its expansion efforts.",0.8130549788475037,0.02972874604165554,0.15721623599529266,positive,0.7833262085914612
26,2017-03-23 00:40:00,The Zacks analyst believes gradual improvement in the economy of WEC Energy's service areas and ongoing investments in infrastructure projects will drive the performance of this regulated company.,0.9181451201438904,0.013054974377155304,0.06879999488592148,positive,0.9050901532173157
27,2017-03-23 00:40:00,"Per the Zacks analyst, Ventas' recent moves to improve its portfolio strength and bolster its position in the healthcare REIT industry will be accretive for it going forward.",0.9532655477523804,0.015376475639641285,0.031357958912849426,positive,0.9378890991210938
28,2017-03-23 00:40:00,"Per the Zacks analyst, DICK'S Sporting's fourth-quarter gained from collapse of rival firms, robust comps and ecommerce growth.",0.9546593427658081,0.024554381147027016,0.020786279812455177,positive,0.9301049709320068
29,2017-03-23 00:40:00,The new merchandise plan also bodes well.,0.7635183930397034,0.016016315668821335,0.2204652577638626,positive,0.7475020885467529
30,2017-03-23 00:40:00,"However, view remains dull.",0.04391765594482422,0.6421273946762085,0.3139549493789673,negative,-0.5982097387313843
31,2017-03-23 00:40:00,"According to the Zacks analyst, General Electric has offered a bullish guidance for 2017 and expects a steady rise in operating profits

Despite macroeconomic headwinds, Carnival is well positioned for continued earnings growth driven by the current strength in its bookings and pricing trends for the year, per the Zacks analyst.",0.9540662169456482,0.017702054232358932,0.028231782838702202,positive,0.9363641738891602
32,2017-03-23 00:40:00,Marriott's buyout of Starwood is likely to lead to a bigger brand with increased scale and a robust development pipeline.,0.9182326197624207,0.012512162327766418,0.06925522536039352,positive,0.9057204723358154
33,2017-03-23 00:40:00,"This should aid in countering macroeconomic headwinds, per the Zacks analyst.",0.9206486344337463,0.01637551560997963,0.06297577917575836,positive,0.9042730927467346
34,2017-03-23 00:40:00,"Per the Zacks analyst, although P&G's cost-cutting plans are helping margins, significant currency headwind, divestitures and slowing market growth have been hurting sales.",0.02336546778678894,0.9660537838935852,0.010580736212432384,negative,-0.9426883459091187
35,2017-03-23 00:40:00,The Zacks analyst believes Intercontinental Exchange's expenses will remain high due to several strategic initiatives.,0.5566002130508423,0.024726316332817078,0.41867348551750183,positive,0.531873881816864
36,2017-03-23 00:40:00,"For 2017, it expects adjusted operating expenses between $1.94 and $1.98 billion.",0.03992490470409393,0.13510917127132416,0.8249658942222595,neutral,-0.09518426656723022
37,2017-03-23 00:40:00,"Per the Zacks analyst, despite improving economy, Robert Half has been facing sluggish U.S. staffing revenues and currency headwinds.",0.026239655911922455,0.9564762115478516,0.017284169793128967,negative,-0.9302365779876709
38,2017-03-23 00:40:00,Lower Protiviti margins are also hurting profits.,0.019247155636548996,0.9700340628623962,0.010718712583184242,negative,-0.9507868885993958
39,2017-03-23 00:40:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
40,2017-03-23 00:40:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069374665617943,0.007019795011729002,0.9422864317893982,neutral,0.04367395117878914
41,2017-03-23 00:40:00,"Click to get this free report

To read this article on Zacks.com click here.",0.02068457007408142,0.033159855753183365,0.9461556077003479,neutral,-0.012475285679101944
42,2017-03-23 00:40:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
